newsfilter
← Latest News
Business Wire·

Graphite Bio Announces Participation in 50th Annual Sickle Cell Disease Association of America National Convention

Graphite Bio, Inc. (NASDAQ:GRPH), a clinical-stage, next-generation gene editing company harnessing the power of high-efficiency precision gene repair to develop therapies with the potential to treat or cure serious